LDR-Brachytherapy monotherapy appears unsuited for NCCN unfavorable intermediate-risk prostate cancer patients

Andreas Boehle*, Dorothea Zywietz, Irina Robrahn-Nitschke, Achim Lusch, Inke R. König

*Corresponding author for this work

Fingerprint

Dive into the research topics of 'LDR-Brachytherapy monotherapy appears unsuited for NCCN unfavorable intermediate-risk prostate cancer patients'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology